RegrowProtocol

Trial pipeline · NCT06603194

Benefit of Bovine or Marine Collagen Vs. Placebo on Skin, Hair, Nails and Whole Body Health in Healthy Adults

Not applicable Recruiting status last verified 2024-09

A registered clinical trial, reproduced from its ClinicalTrials.gov record. Every value on this page is a field on that record. Nothing on this page is a finding, an assessment or a recommendation.

The registered record

Accession number
NCT06603194
Lead sponsor
Ancient + Brave (industry)
Collaborators
Princeton Consumer Research
Registered condition naming hair loss
Hair Thinning
Also registered on this record
Skin LaxityNails
Official title
BECOME Study: Comparative Efficacy of Bovine and Marine Collagen Versus Placebo on Skin, Hair, Nails and Whole Body Health Markers

The first row holds the registered condition that placed this trial on the pipeline; the second holds everything else the sponsor registered on the same record. Both are shown, and shown apart rather than shaded differently, because leaving the second out would make this trial look more like a hair-loss study than its registration says it is — and because a distinction carried only by colour is not a distinction for every reader.

Interventions

  • Dietary supplementBovine or Marine Collagen

Names and types as registered. The sponsors' free-text descriptions of these interventions are not reproduced: they are written by the party with an interest in the result, and reprinting them inside this site's layout would lend them this site's voice.

Design

Study type
interventional
Phase
Not applicable
Allocation
randomized
Masking
single
Primary purpose
prevention
Enrolment
90 participants (estimated)
Sites
1 location in United Kingdom

What it measures

  1. Change in nail strength and growth

    Time frame: Baseline, week 6 and week 12

  2. Change in skin elasticity

    Time frame: Baseline, week 6 and week 12

  3. Change in hair thickness and strength

    Time frame: Baseline, week 6 and week 12

  4. Change in skin wrinkles

    Time frame: Baseline, week 6 and week 12

  5. Change in perceived skin health

    Time frame: Baseline, week 6 and week 12

  6. Change in skin wrinkles by visual assessment

    Time frame: Baseline, week 6 and week 12

  7. Changes in skin pigmentation

    Time frame: Baseline, week 6 and week 12

  8. Changes in skin hydration

    Time frame: Baseline, week 6 and week 12

Primary outcome measures only, as registered. What a trial chose to measure, and when, is the most informative thing about it that is knowable before it reports — a hair-count endpoint at 24 weeks and a patient-satisfaction endpoint at 12 weeks are not the same study.

Who can take part

Sex
female
Age
35 Years to 55 Years
Healthy volunteers
accepted

A summary of three registered fields, not the eligibility criteria. The full inclusion and exclusion criteria, the recruiting sites and the study contacts are on the registry record, which is the only place they are maintained. This site has no relationship with this trial and cannot refer anyone to it.

Registered dates

Study start
26 August 2024 (actual)
Primary completion
25 November 2024 (estimated)
Study completion
20 December 2024 (estimated)
First posted
19 September 2024 (actual)
Last update posted
19 September 2024 (actual)

"Estimated" and "actual" are the registry's own labels: an estimated date is a plan, and plans move. A date is printed at the precision it was registered at: this record registers a primary completion to the day, so a day is what is shown. Where a sponsor registers only a month, only a month is shown.

Results

This trial has not reported results. ClinicalTrials.gov holds no results record for it. That is the ordinary state of a trial that is running or about to run, and it means there is nothing here to tell you about whether the intervention works — including nothing negative. If this page implied otherwise it would be wrong.

On this site

Guides covering the condition this trial is registered for. They are about published evidence; this page is about a registration, and the two do not overlap.

Where this came from

Read from the ClinicalTrials.gov API on 6 September 2026 and rebuilt into this page without alteration. ClinicalTrials.gov is a service of the U.S. National Library of Medicine and is the authority on this record; where this page and the registry disagree, the registry is right. This page is not affiliated with or endorsed by NLM or NIH, or with the sponsor of this trial.

Open NCT06603194 on ClinicalTrials.gov · All 157 trials in the pipeline